Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC
Activating mutations in <i>Kirsten rat sarcoma viral oncogene homologue (KRAS)</i>, in particular, a point mutation leading to a glycine-to-cysteine substitution at codon 12 (G12C), are among the most frequent genomic alterations in non-small cell lung cancer (NSCLC). Several agents targeting KRAS G...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI AG
2023-07-01
|
| Серии: | Current Oncology |
| Предметы: | |
| Online-ссылка: | https://www.mdpi.com/1718-7729/30/7/476 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|